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Abstract—The purpose of this study was to evaluate the effect of intravenously administered tiletamine-
zolazepam on the response of cats to intradermal injections of varying concentrations of histamine, thereby 
giving an indication of the feasibility of using tiletamine-zolazepam for the restraint of cats during 
intradermal skin testing. 
Ten cats were injected intradermally with increasing concentrations of histamine and a negative control 
before and after anesthesia with tiletamine-zolazepam (5 mg.kg - 1 intravenously). The wheals produced by 
the eight different concentrations of histamine (1:100,000 to 1:9,600,000) and the negative control before and 
after anesthesia were compared in each cat. There was no significant difference in the response to the 
intradermal histamine injections before and after anesthesia. It was concluded that 4mg.kg~ l of tiletamine-
zolazepame administered intravenously may be a good anesthetic choice for intradermal skin testing in cats. 
Key Words: Intradermal skin testing; Cats; Tiletamine-zolazepam. 
I N T R O D U C T I O N 
Atopy (atopic dermatitis, allergic inhalant dermatitis) 
is a well recognized allergic skin disease in the dog (1 , 
2, 3). Affected individuals have an inherited predispo-
sition to form IgE antibodies against environmental 
allergens and subsequently develop pruritic skin dis-
ease following re-exposure to these allergens. Canine 
atopy is classified as a type I hypersensitivity reaction 
where binding of allergens to mast cell fixed IgE or 
IgGd leads to degranulation and release of pharmaco-
logically active compounds ( 1 , 3, 4). A similar disease 
is recognized in humans (5, 6, 7). 
The diagnosis of atopy in cats is based on intra-
dermal skin testing and response to hyposensitiza-
tion (9, 10, 11, 12). However, feline IgE has not been 
conclusively identified, even though a reaginic anti-
body was detected in cats with positive skin test 
reactions (8), which supports the premise that an IgE 
like antibody exists in cats. 
Intradermal skin testing is the most commonly 
utilized procedure for the diagnosis of canine atopy 
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(1). Physical restraint can be problematic and 
intradermal skin test results can be influenced by 
endogenous corticosteroid and/or epinephrine release 
in dogs (1 , 2). Thus, immobilization with xylazine 
hydrochloride, tiletamine-zolazepam, short acting 
barbiturates or inhalation anesthesia has been recom-
mended (2, 3, 13, 14, 15, 16). 
Intradermal skin testing is not easily accomplished 
in the cat utilizing physical restraint alone. Movement 
can be expected, which may affect the quality of 
injections and influence the results of the skin 
test. Additionally, release of glucocorticoids and 
epinephrine would be expected to reduce skin test 
reactivity as reported in the dog ( 1 , 2). Ketamine has 
been recommended as a satisfactory anesthetic for 
skin testing in cats ( 1 , 2). Ketamine and diazepam in 
combination also have been used (17). 
A new dissociative anesthetic product containing 
a 1:1 mixture by weight of tiletamine as dissocia-
tive and zolazepam as benzodiazepine, is approved as 
an injectable anesthetic agent for dogs and cats 
(Telazol, A. H . Robbins, Richmond, VA) . Intra-
venous use produces effective chemical restraint for 
short diagnostic and minor surgical procedures (J. 
Ilkiw, Veterinary Medical Teaching Hospital, Univer-
sity of California, Personal communication, 1991). 
Tiletamine-zolazepam anesthesia recently was re-
ported by Codner to be a good choice for intradermal 
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skin testing in the dog (13, 14). Diminution of skin 
test reactivity would be unlikely as tiletamine does not 
have antihistaminic action (18) and interaction of 
zolazepam and histamine has not been reported (14). 
The purpose of this study was to evaluate the effect 
of intravenously administered tiletamine-zolazepam 
on the response of cats to intradermal injections of 
varying concentrations of histamine, thereby giving 
an indication of the feasibility of using tiletamine-zo­
lazepam for the restraint of cats during intradermal 
skin testing. 
M A T E R I A L S AND M E T H O D S 
Eight female and three male domestic short haired 
cats from a colony of cats with a genetic predisposi­
tion to the development of feline eosinophilic granu­
loma at the University of California/Davis (19) were 
used in the study. On physical examination, all cats 
had normal haircoat and underlying skin. An indo­
lent ulcer was present on the upper lip in one cat and 
ulcerations of the hard palate typical of eosinophilic 
granuloma were seen in two additional cats. A biopsy 
of these lesions confirmed the diagnosis (19). Ten cats 
had not received any topical or parenteral medication 
for at least two months prior to the study. The 
eleventh cat had completed a two-week-course of 
topical medication containing nystatin, neomycin sul­
fate, thiostreptone and triamcinolone acetonide 
(Panolog, Solvay Veterinary, Princeton, NJ) which 
was applied twice a day to an eosinophilic granuloma 
lesion in the preauricular region 14 days previously. 
A protocol previously described was utilized (14). 
Skin testing was performed in all eleven cats on 
the left lateral thorax using only physical restraint. 
Skin testing was then repeated six hours later on the 
right lateral thorax utilizing tiletamine-zolazepam 
anesthesia. 
An area of approximately 10 χ 5 cm on the left 
lateral thorax of each cat was clipped with an electric 
clipper (Oster Clippers, Milwaukee, Wis.) using a No. 
40 blade. Nine injection sites were marked with a 
permanent marker pen (Sharpie, Sanford Corp., Bell-
wood, IL . ) . One diluent control (Sterile diluent for 
allergenic extracts, buffered saline; Greer Laborato­
ries, Lenoir, N C ) , and eight diminishing dilutions of 
histamine (Histamine phosphate 2.75mg/ml; Lily, 
Indianapolis, IN.) (1:100,000; 1:200,000; 1:400,000; 
1:800,000; 1:1.600,000; 1:2,400,000; 1:4,800,000 and 
1:9,600,000) were injected intradermally two cm apart 
in two horizontal rows. Only one injection of each 
dilution was made due to the size constraints of the 
thorax of cats and the increasing resistance of unanes-
thetized cats to the injection procedure. A volume of 
0.05 ml was injected at each site using one milliliter 
tuberculin syringes and 26 gauge needles with in­
tradermal bevels (Precision glide 26G 3/8 Becton 
Dickinson, Rutherford, NJ.). Fifteen minutes after 
injection, the wheals were graded from zero to four, 
based on size, elevation, erythema and induration 
(subjective evaluation). The diluent was used as a 
negative control and graded as zero, the most concen­
trated histamine dilution (1:100,000) served as a 
positive control and was classified as a four. The 
diameter of the wheals was measured in mm (objec­
tive evaluation). 
Six hours later, each cat was administered 4 mg/kg 
tiletamine-zolazepam intravenously. The right lateral 
thorax was clipped in the corresponding area and the 
same procedure carried out as described above. 
Wheals were evaluated in a similar manner. 
Subjectively graded responses to histamine injec­
tion at various dilutions before and after anethesia 
were compared using the nonparametric sign test for 
matched pairs. Objectively measured responses to 
histamine injection at various dilutions were com­
pared using the paired T-test and the nonparametric 
Wilcoxin paired test for signed ranks. Hotelling's Τ 
square test was used to test the null hypothesis that 
all differences in mean wheal diameter were simulta­
neously zero. Linear and polynomial regression was 
used to see i f differences in wheal diameter systemat­
ically varied with log histamine dilution. A l l analyses 
were performed using B M D P statistical software 
(20). Statistical adjustment for multiple comparisons 
to maintain a nominal level of significance of 0.05 was 
performed using the sequentially rejective multiple 
test procedure of Holm (20). 
R E S U L T S 
Tiletamine-zolazepam 4 m g . k g _ 1 intravenously im­
mobilized all cats for 20 to 40 minutes. Except for 
muscle tremors of the limbs, recovery was uneventful 
in all cats. 
The median values of the subjective grading in­
creased from zero to four without anesthesia and 
from zero to four with anesthesia as histamine con­
centration increased. Similarly, the mean diameter of 
the wheals increased in size from 4 to 11 mm and from 
4.4 to 11.3 mm respectively (Table 1). 
There was no significant difference between the 
mean wheal diameter values before and after anesthe­
sia at each histamine solution. However, 12 of the 90 
injection pairs showed a difference of more than one 
grade in the subjective evaluation and 21 injection 
sites varied more than three mm in wheal diameter. 
The eleventh cat which received a corticosteroid-
containing ointment two weeks prior to the study 
exhibited only a minimal response to all the intrader­
mal injections including the most concentrated his­
tamine dilution. Since it was probable that the 
previous therapy had suppressed skin test reactivity, 
this cat was not included in the statistical evaluation 
of the larger study. 
Al l pairwise tests indicated that there was no 
significant difference (p>0.05) in mean response to 
the intradermal injections before and after anesthesia. 
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Hotelling's Τ square test was not significant 
(p > 0.05), providing further evidence that the differ­
ences in mean wheal diameter at all dilutions were 
simultaneously zero. In addition, regression methods 
showed no evidence of a linear, quadratic, or cubic 
trend in the mean differences at different loghistamine 
dilutions. 
DISCUSSION 
Based on the result of this study, tiletamine-
zolazepam appears to be an appropriate anesthetic 
for intradermal skin testing in cats. Four rng.kg" 1 
tiletamine-zolazepam intravenously did not have a 
significant effect on wheal and flare response to intra­
dermal injections of varying solutions of histamine. 
As would be expected, the mean values of the 
subjective evaluation decreased with diminishing dilu­
tions of histamine, the diameter of the wheals de­
creased similarly. 
Feline atopy is believed to be a type I hypersensitiv­
ity. Thus, response to intradermal injections of his­
tamine should produce wheal and flare reactions 
similar to those which allergens would produce in an 
atopic cat. The subjective grading from zero to four 
corresponds to currently employed grading responses 
to intradermally injected allergenic extracts in skin 
testing. The diluent serves as a negative control and 
histamine (1:100.000) as a positive control; the former 
being graded as zero, the latter as four. 
Cats have thinner skin than dogs, thus, intradermal 
injections are more difficult to accomplish. Accidental 
subdermal injection is more likely to occur than in the 
dog. The variability in both the subjective ( > 1 grade) 
and objective ( > 3 mm) evaluation may in part be due 
to this. 
In the subjective evaluation, a difference of more 
than one grade in the response to the intradermally 
injected histamine dilutions before and after anesthe­
sia was noted twelve times. The reaction was more 
pronounced before anesthesia in six cases and after 
anesthesia in the other six. 
Twenty-one of the 90 injection pairs showed a 
difference of more than three mm in the objective 
evaluation. Eight of these pairs were injections with 
either the negative control or the lowest histamine 
dilution, where one injection created a wheal and the 
other one did not. In ten of the 21 pairs, the wheal size 
was increased before anesthesia and in eleven of the 
pairs the wheal size was increased after anesthesia. 
Only one of the 21 varied more than one unit in the 
subjective gradings, which took into account not only 
size, but also the induration, elevation and erythema 
of the wheals. 
Results seen in the eleventh cat show the possible 
influence of topical application of glucocorticoids on 
intradermal skin testing in cats. Topical absorption of 
glucocorticoids has been shown to produce adrenal 
suppression and iatrogenic hyperglucocorticoidism in 
dogs (21, 22, 23). 
The cats in this study are part of a research colony 
and are habituated to handling and minor diagnostic 
procedures. Cats that are not commonly restrained 
could be expected to show substantially more resis­
tance to the injections. Thus, it may be difficult to 
consistently inject the same amount of allergenic 
extract intradermally. Also, stress and subsequent 
endogenous release of epinephrine and corticosteroid 
may reduce dermal reactivity and thus interfere with 
skin test results. 
Four rng.kg" 1 of tiletamine-zolazepam adminis­
tered intravenously anesthesized all cats for a time 
period of between 20 and 40 minutes. This provides 
adequate time for the skin testing procedure and 
subsequent evaluating 15 minutes after the intrader­
mal injections of the allergen extracts. 
The dose of the anesthetic should be reduced in 
geriatric or debilitated cats and because the drug is 
excreted by the kidneys, in animals with impaired 
renal function. It is contraindicated in cats with 
pancreatic disorders and severe cardiac or pulmonary 
dysfunction (Package insert, Telazol, Animal Health 
Group, A. H . Robbins Company, Richmond, VA, 
1978). 
This study suggests, that tiletamine-zolazepam at 
4 rng.kg"1 IV may be a good anesthetic choice for 
intradermal skin testing in cats, since it did not 
interfere with the response to different dilutions of 
histamine intradermally. However, clinical trials are 
necessary to evaluate the influence of this anesthetic 
on the response to various intradermally injected 
allergenic extracts in atopic cats. 
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Tiletamine-zolazepam for intradermal testing in cats 
Resume—Le but de cette etude etait d'evaluer rinfluence d'une injection intravcineuse de tiletamine-
zolazepam sur la reponse de chats ä des injections intradermiques de differentes concentration d'histamine, 
afin de savoir si une une anesthesie ä Taide de tiletamine-zolazepam etait utilisable pour faire des tests 
cutanes chez le chat. Des concentrations croissantes d'histamine et un temoin negative ont ete injectes par 
voie intradermique ä dix chats avant et apres injection IV de tiletamine-zolazepam (5 mg/kg). Le diametre 
des papules aux neufs concentrations differentes d'histamine (1:100 000, 1:2 800 000, 1:4 800 000 et 1:9 
600 000) et au temoin negatif ont ete compares pour chaque chat avant et apres aesthesie. II n'existait de 
difference significative avant et apres anesthesie. II a ete conclu qu'une anesthesie ä faide de 5 mg IV de 
tiletamine-zolazepam etait utilisable pour effectuer des intradermoreactions chez le chat. [Mueller, R. S., 
Ihrke, P. J., Kass, P. H. Bettenay, S. V. The effect of tiletamine-zolazepam anesthesia on the response to 
intradermally injected histamine in cats (Etude de rinfluence d'une anesthesie ä faide de tiletamine-
zolazepam sur la reponse a des injections intradermiques d'histamine chez le chat). Veterinary Dermatology 
1991: 2: 119-123]. 
Zusammenfassung—Ziel dieser Studie war die Austwertung der Wirkung von intravenös verabreichtem 
Tiletamin-Zolazepam auf die Reaktion von Katzen gegenüber intradermal injiziertem Histamin unter-
schiedlicher Konzentrationen. So ergeben sich Hinweise auf die Eignung von Tiletamin-Zolazepan für die 
Ruhigstellung von Katzen bei intradermalen Hauttests. Bei zehn Katzen wurde Histamin in steigenden 
konzentrationen zusammen mit einer Negativkontrolle intradermal vor und nach Anästhesie mit Tiletamin-
Zolazepam (5 mg/kg intravenös) injiziert. Bei jeder Katze wurden die Negativkontrollen und die lokalen 
Schwellungen durch die neun verschiedenen Histaminkonzentrationen (1:100,000-1:9,600,000) vor und nach 
der Anästhesie verglichen. Es ergaben sich keine signifikanten Unterschiedge in den Reaktionen auf 
intradermale Histamininjektionen vor und nach der Anästhesie. Daraus läßt sich schlußfolgern, daß 5 mg 
Tiletamin-Zolazepam, intravenös verabreicht, eine gute Anästhesiemöglichkeit für Hauttests bei Katzen 
darstellen. [Mueller, R. S., Ihrke, P. J., Kass, P. H , Bettenay, S. V. The effect of tiletamin-zolazepam 
anesthesia on the response to intradermally injected histamine in cats. (Die Wirkung einer Tiletamin-Zo-
lazepam-Anästhesie auf die Reaktion gegenüber intradermal injiziertem Histamin bei Katzen). Veterinary 
Dermatology, 1991; 2: 119-123]. 
Resumen — El presente reportaje tiene como objetivo el estudio de la administracion intravenosa de 
tiletamina-zolazepäm en la respuesta de un grupo de gatos sometidos a la inyeccion intradermica de 
diferentes concentraciones de histamina, dando asi una indicacion de la utilidad de tiletamina-zolezopan 
para la inmobilizaciön de gatos durante el test de la inyeccion intrdermica. Se inyectaron intradermicamente 
diez gatos con concentraciones crecientes de histamina y un control negativo, antes y despues de la anestesia 
producida con tiletamina-zolazepäm (5 mg/kg de forma intravenosa). Luego se comparon las ronchas 
producidas por las diferentes concentraciones de histamina (1:100,000-1:9,600,000) y el control negativo, 
antes y despues de la anestesia. No hubo diferencia significativa en la respuesta a la inyeccion intradermica 
de histamina antes ο despues de la anestesia. Asi, se concluyo que la administracion de 5 mg de 
tiletamina-zolazepäm de forma intravenosa podn'a ser un anestetico satisfactorio en el test intradermico 
llevado a cabo en gatos. [Mueller, R. S., Ihrke, P. J., Kass, P. H., Bettenay, S. V. The effect of 
tiletamine-zolazepam anesthesia on the response to intradermally injected histamine in cats (El efecto de la 
anestesia producida por tiletamina-zolezepam en la respuesta de gatos inyectados intradermicamente con 
histamina). Veterinary Dermatology, 1991; 2: 119-123]. 
